Novartis AG ADS (NVS)



Novartis is a pharmaceutical group based in Switzerland. Co. specializes in the research, development, manufacturing and marketing of healthcare products. Co.'s portfolio includes medicines, eyecare, preventive vaccines and diagnostic tools, generic pharmaceuticals and consumer health products. Co.'s operations are organized along five business divisions: Pharmaceuticals (patent-protected prescription medicines); Alcon (vision care products); Sandoz (generic parmaceuticals); Vaccines and Diagnostics (Human vaccines and blood-testing diagnostics); and Consumer Health (Over-the-counter medicines; veterinary products for farm and companion animals; and contact lenses and lens-care products).

Data as of 2020-07-04
Market Cap200.42 Billion Shares Outstanding2.289 Billion Avg 30-day Volume1.837 Million
P/E Ratio16.7 Dividend Yield3.526 EPS5.28
Price/Sales5.937 Price cash flow ratio14.6 Price free cash flow ratio-17.7
Book Value22.24 Price to Tangible Book-12.93 Alpha-0.0
Short Interest Ratio0.88 % Short Interest to Float0.1 R-squared0.281742
BETA0.673976 52-week High/Low99.8429 / 69.1801 Stddev0.054072
View SEC Filings from NVS instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 28 6 (0.39%)
13F Filers holding this stock: 1086 170 (11.13%)
Aggregate 13F shares on 03/31/2020: 247.169 Million 75.319 Million
Aggregate 13F shares on 12/31/2019: 257.343 Million 75.8 Million
Percent change: -3.95% -0.64%
Funds creating new positions: 86 18
Funds Adding to an existing position: 407 68
Funds closing out their position: 112 29
Funds reducing their position: 437 63
Heat Map Ranking for 03/31/2020 154
Heat Map Ranking for 12/31/2019 180
1 hedge funds as identified by through public filings.

Funds Holding NVS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NVS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)


Open Market Sells (S)


Exercise Derivative Conversion (M)


Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments